Every year, as a valued customer, you have the exclusive opportunity to explore and enjoy three different trial products of your choice, absolutely free!
10μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$36.90
Ab190289-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$174.90
Ab190289-25μg
25μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
Receptor for TNFSF18. Seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death. Mediated NF-kappa-B activation via the TRAF2/NIK pathway.
Host species
Rat
Specificity
GITR/CD357
Immunogen
Mouse CD25+ CD4+ T cells
Positive Control
Flow: C57BL/6 mouse splenocytes.
Conjugation
Biotin
Grade
ExactAb™, Validated
Product Description
Rat anti Mouse GITR/CD357 Antibody, Monoclonal (DTA-1), could be used for Flow
Product Properties
Isotype
Rat IgG2b
Light Chain Type
lambda
Purification Method
Protein G purified
Concentration
0.5 mg/mL
Storage Temp
Store at 2-8°C,Protected from light,Freeze prohibited
Shipped In
Wet ice
Stability And Storage
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Images
GITR/CD357 Rat mAb (Biotin) (Ab190289) - Flow Cytometry Two-color flow cytometric analysis of GITR/CD357 expression on mouse splenocytes. C57BL/6 mouse spleen cells were stained with CD25 Rat mAb (APC) (Ab179012) and either Rat IgG Isotype Control Antibody (Biotin) (Ab180310; Left panel) or GITR/CD357 Rat mAb (Biotin) (Ab190289; Right panel) at 1 μg/mL. Then incubated with Recombinant Streptavidin Protein (R-PE) (rp156150) at 0.1μg/test for 30 minutes at 4°C in the dark. Total viable cells were used for analysis.
Associated Targets
TNFRSF18Tbio Tumor necrosis factor receptor superfamily member 18 0 Activities
